Vir Biotechnology (VIR) EBT Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -42.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.89 Mn |
| Dec 31, 2025 | 77,872.00 |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -457,660.00 |
| Mar 31, 2025 | -386,336.00 |
| Dec 31, 2024 | -12,658.00 |
| Sep 30, 2024 | -265,829.00 |
| Jun 30, 2024 | 65,545.00 |
| Mar 31, 2024 | 10,171.00 |
| Dec 31, 2023 | -41,245.00 |
| Sep 30, 2023 | -637,211.00 |
| Jun 30, 2023 | -462,946.00 |
| Mar 31, 2023 | -30,224.00 |
| Dec 31, 2022 | -37,406.00 |
| Sep 30, 2022 | -4,877.00 |
| Jun 30, 2022 | -61,202.00 |
| Mar 31, 2022 | 861,301.00 |
| Dec 31, 2021 | 680,102.00 |
| Sep 30, 2021 | 449,419.00 |
| Jun 30, 2021 | 10,863.00 |
| Mar 31, 2021 | -718,767.00 |
| Dec 31, 2020 | -24,181.00 |
| Sep 30, 2020 | -94,275.00 |
| Jun 30, 2020 | 158,465.00 |
| Mar 31, 2020 | -56,742.00 |
| Dec 31, 2019 | -564,837.00 |
| Sep 30, 2019 | -228,489.00 |